• Poster

Quality of Life and Quality-Adjusted Survival (Q-TWiST) in Patients Receiving Lapatinib Plus Letrozole as First-Line Therapy in Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Citation

Sherrill, B., Sherif, B. N., Amonkar, M., Wu, Y., Maltzman, J., O'Rourke, L., & Johnston, S. (2009, October). Quality of Life and Quality-Adjusted Survival (Q-TWiST) in Patients Receiving Lapatinib Plus Letrozole as First-Line Therapy in Hormone Receptor Positive, HER2+ Metastatic Breast Cancer. Presented at 2009 Breast Cancer Symposium, .

Abstract